← Leaderboards
Louise Henderson
Univ Of North Carolina Chapel Hill
$9,735,205
Attributed
$14,100,982
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,506,116 · 12
By mechanism
R01$10,828,978 · 6
UG1$2,295,500 · 1
R21$754,490 · 2
U01$405,134 · 1
P30$222,014 · 2
Top collaborators
- M Patricia Rivera6 shared
- Jennifer Lund4 shared
- Carrie B Lee3 shared
- Daniel S. Reuland3 shared
- Angela M Stover2 shared
- Florian J. Fintelmann1 shared
- Lori Sakoda1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Bryce B Reeve$11,567,326
- Amanda E Nelson$9,806,242
- Andrew Olshan$26,924,096
- Sarah Jane Nyante$3,341,530
- Jennifer Lund$988,197
Others in their field
Top investigators on “North Carolina”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- J Brooks Jackson · Social And Scientific Systems, Inc.$151,807,671
- Myron S Cohen · Family Health International$150,717,199
- Wafaa M. El-Sadr · Columbia University Health Sciences$146,816,419
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$118,674,703
Research focus
North CarolinaScreeningRegistriesFollow-UpRecommendationLungPopulation BasedMortalityScreening For CancerCancer ControlSurveysInnovationMalignant Neoplasm Of LungRadiologistPatternGuidelinesMalignant Breast NeoplasmMalignant NeoplasmsCancer EtiologyCancer DetectionEvidence BaseLung Cancer ScreeningNeoplasm RegistryCessation Of Life
Grant awards (36)
OPTimizing surveillance in lung cancer survivors with novel IMAging biomarkers and deep-Learning (OPTIMAL)$968,999
R01 · FY2025 · CA · contact PI
Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)$875,106
UG1 · FY2025 · CA
Lung Cancer Screening: Cumulative Risk and Multilevel Impact of False Positive Findings$643,636
R01 · FY2025 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings$593,415
R01 · FY2025 · CA · contact PI
Administrative Supplement: CSRN Vanguard Study$544,248
UG1 · FY2025 · CA
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening$355,706
R01 · FY2025 · CA
Cancer Epidemiology Research Program$46,263
P30 · FY2025 · CA · contact PI
Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)$876,146
UG1 · FY2024 · CA
Lung Cancer Screening: Cumulative Risk and Multilevel Impact of False Positive Findings$657,536
R01 · FY2024 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings$507,725
R01 · FY2024 · CA · contact PI
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening$331,216
R01 · FY2024 · CA
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening - NCI Diversity Supplement$75,159
R01 · FY2024 · CA
Cancer Epidemiology Research Program$40,559
P30 · FY2024 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings$546,105
R01 · FY2023 · CA · contact PI
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening$403,840
R01 · FY2023 · CA · contact PI
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening$348,648
R01 · FY2023 · CA
Cancer Epidemiology Research Program$45,064
P30 · FY2023 · CA · contact PI
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening$410,615
R01 · FY2022 · CA · contact PI
Cancer Epidemiology Research Program$45,064
P30 · FY2022 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry$610,662
R01 · FY2021 · CA · contact PI
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening$390,841
R01 · FY2021 · CA · contact PI
Cancer Epidemiology Research Program$45,064
P30 · FY2021 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry$611,504
R01 · FY2020 · CA · contact PI
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening$327,967
R01 · FY2020 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry$618,327
R01 · FY2019 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry$640,870
R01 · FY2018 · CA · contact PI
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry$628,514
R01 · FY2017 · CA · contact PI
Evaluating the Effect of the Breast Density Legislation on Supplemental Screening$142,120
R21 · FY2017 · CA · contact PI
Evaluating the Effect of the Breast Density Legislation on Supplemental Screening$248,710
R21 · FY2016 · CA · contact PI
Technologists Effect on the Accuracy of Mammography (TEAM)$303,845
R01 · FY2015 · CA · contact PI
Developing a Lung Cancer Screening Registry in a State with a High Smoking Rate$165,300
R21 · FY2015 · CA · contact PI
Technologists Effect on the Accuracy of Mammography (TEAM)$294,792
R01 · FY2014 · CA · contact PI
Developing a Lung Cancer Screening Registry in a State with a High Smoking Rate$198,360
R21 · FY2014 · CA · contact PI
Technologists Effect on the Accuracy of Mammography (TEAM)$285,733
R01 · FY2013 · CA · contact PI
Technologists Effect on the Accuracy of Mammography (TEAM)$273,323
R01 · FY2012 · CA · contact PI
Carolina Mammography Registry$405,134
U01 · FY2009 · CA · contact PI